Emily Rayner
0000-0002-0477-9408
Publication & Citation Trends
Publications
0 total
Unexpected moves: a conformational change in MutSα enables high-affinity DNA mismatch binding OA
Cited by 9
Semantic Scholar
Functional assay-based classification of PMS2 variants in Lynch Syndrome OA
Cited by 1
Semantic Scholar
CRISPR-Cas9 Causes Chromosomal Instability and Rearrangements in Cancer Cell Lines, Detectable by Cytogenetic Methods OA
Cited by 56
Semantic Scholar
Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response OA
Cited by 94
Semantic Scholar
Adjuvant treatment for POLE proofreading domain-mutant cancers: sensitivity to radiotherapy, chemotherapy, and nucleoside analogs Running title: Adjuvant treatment for POLE-mutant cancers Authors:
Cited by 0
Semantic Scholar
Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues OA
Cited by 72
Semantic Scholar
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study. OA
Cited by 271
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(26)
Genetic factors in colorectal cancer
(9)
Advanced biosensing and bioanalysis techniques
(6)
RNA Interference and Gene Delivery
(6)
Ovarian cancer diagnosis and treatment
(5)
Affiliations
Centre for Human Genetics
Leiden University Medical Center
University of Oxford
University of Birmingham